Your browser doesn't support javascript.
loading
Olfactory loss in people with cystic fibrosis: Community perceptions and impact.
Miller, Jessa E; Liu, Christine M; Zemanick, Edith T; Woods, Jason C; Goss, Christopher H; Taylor-Cousar, Jennifer L; Beswick, Daniel M.
Afiliação
  • Miller JE; University of California, Los Angeles, Department of Otolaryngology-Head and Neck Surgery, Los Angeles, CA, USA.
  • Liu CM; University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA, USA.
  • Zemanick ET; University of Colorado School of Medicine, Department of Pediatrics, Aurora, CO, USA.
  • Woods JC; Cincinnati Children's Hospital Medical Center, Department of Radiology, Cincinnati, OH, USA.
  • Goss CH; University of Washington, Department of Pulmonary Medicine, Seattle, WA, USA.
  • Taylor-Cousar JL; National Jewish Health, Departments of Medicine and Pediatrics, Denver, CO, USA; University of Colorado Anschutz Medical Campus, Departments of Internal Medicine and Pediatrics, Aurora, CO, USA.
  • Beswick DM; University of California, Los Angeles, Department of Otolaryngology-Head and Neck Surgery, Los Angeles, CA, USA. Electronic address: dbeswick@mednet.ucla.edu.
J Cyst Fibros ; 2023 Nov 17.
Article em En | MEDLINE | ID: mdl-37981480
ABSTRACT

BACKGROUND:

Olfactory dysfunction (OD) is prevalent in people with cystic fibrosis (PwCF) and can negatively impact quality-of-life (QOL). This study evaluated perceptions of OD, investigated how OD impacts QOL, and assessed willingness to participate in OD research among the CF community.

METHODS:

A 21-question survey was distributed through the CF Foundation's Community Voice program in 2023. The survey included questions on olfaction and interest in research. The Brief Questionnaire of Olfactory Disorders (BQOD), a validated person-reported outcome measure to assess QOL, was included.

RESULTS:

Seventy-six responses were received. Overall, 91% (69/76) reported olfactory problems. Mean BQOD score was 5.0 (standard deviation=4.8), indicating olfactory QOL impairment was present. Ninety-five percent (72/76) reported research on OD is worthwhile and were willing to participate in research.

CONCLUSION:

Among PwCF, OD and olfactory-specific QOL impairments are prevalent. There is strong interest and willingness to participate in OD research among the CF community.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article